LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

PHASE2CompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

December 13, 2011

Primary Completion Date

April 8, 2016

Study Completion Date

April 12, 2019

Conditions
Lung Neoplasms
Interventions
DRUG

Afatinib

afatinib once daily

DRUG

gefitinib

Gefitinib once daily

Trial Locations (63)

8

St James's Hospital, Dublin

100

National Taiwan University Hospital, Taipei

112

Taipe Veterans General Hospital, Taipei

333

Chang Gung Memorial Hospital(Linkou), Taoyuan District

407

Taichung Veterans General Hospital, Taichung

704

NCKUH, Tainan City

2050

Chris Obrien Lifehouse, Camperdown

2217

St George Hospital, Kogarah

3084

Austin Health, Heidelberg

3128

Box Hill Hospital, Box Hill

4032

The Prince Charles Hospital, Chermside

4101

Haematology & Oncology Clinics of Australasia (HOCA), South Brisbane

6009

Sir Charles Gairdner Hospital, Nedlands

14076

CTR François Baclesse, Caen

28041

Hospital Universitario 12 de Octubre, Madrid

29010

Hospital Regional Universitario de Málaga, Málaga

33006

Hospital Central de Asturias, Oviedo

38700

HOP Michallon, La Tronche

39008

Hospital Universitario Marqués de Valdecilla, Santander

41013

Hospital Virgen del Rocío, Seville

44805

CTR René Gauducheau, Saint-Herblain

45122

Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH, Essen

55131

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz

64100

CTR Oncologie du Pays Basque, Onco, Bayonne, Bayonne

69373

CTR Leon Berard, Lyon

73730

Klinikum Esslingen GmbH, Esslingen am Neckar

87042

HOP Dupuytren 1, Limoges

94010

HOP Intercommunal, Créteil

97448

HOP Sud-Réunion, Pneumo, Saint Pierre, St-Pierre - La Réunion

100021

Cancer Hospital of Chinese Academy of Medical Science, Beijing

100036

Beijing Cancer Hospital, Beijing

110001

The First Hospital of Chinese Medical University, Shenyang

169610

National Cancer Centre, Singapore

200030

Shanghai Chest Hospital, Shanghai

200032

Zhongshan Hospital Fudan University, Shanghai

308433

Johns Hopkins Singapore International Medical Center, Singapore

510060

Sun Yat-Sen University Cancer Center, Guangzhou

530021

The Affiliated Cancer Hospital, Guangxi Medical University, Nanning

T6G 1Z2

Cross Cancer Institute (University of Alberta), Edmonton

V1V 1Z2

British Columbia Cancer Agency (BCCA) - Fraser Valley Cancer, Surrey

V5Z 4E6

BC Cancer Agency - Vancouver, Vancouver

L1G 2B9

Lakeridge Health Oshawa, Oshawa

K1H 8L6

The Ottawa Hospital, Ottawa

H3G 1A4

Montreal General Hospital - McGill University Health Centre, Montreal

Unknown

Queen Mary Hospital, Hong Kong

Prince of Wales Hospital, Shatin

D09 Y5R3

Beaumont Hospital, Dublin

N-0379

Oslo Universitetssykehus HF, Radiumhospitalet, Oslo

361-771

Chungbuk National University Hospital, Cheongju-si

405-760

Gachon University Gil Medical Center, Incheon

110-744

Seoul National University Hospital, Seoul

120-752

Severance Hospital, Seoul

135-710

Samsung Medical Center, Seoul

138-736

Asan Medical Center, Seoul

413 45

Sahlgrenska US, Göteborg, Gothenburg

581 85

Universitetssjukhuset, Linköping, Linköping

221 85

Skånes universitetssjukhus, Lund, Lund

171 76

Karolinska Univ. sjukhuset, Stockholm

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

B18 7QH

Birmingham City Hospital, Birmingham

CF14 2TL

Velindre Cancer Centre, Cardiff

EH4 2XU

Western General Hospital, Edinburgh

GU2 7XX

Royal Surrey County Hospital, Guildford

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY